Resources ContraVir Pharmaceuticals Announces $9.0 Million Private Placement May 6, 2020 Read More › CEL-SCI Corporation Announces $6.0 Million Public Offering May 6, 2020 Read More › Towerstream Corporation Announces $35.0 Million Secured Financing May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Advises Single Touch on a $11.0 M Debt and Equity Financing Consisting of a $10.0 M Secured Financing and a $1.0 M PIPE with Fortress Investment Group May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Advises Rightscorp, Inc. on a $2.65M PIPE Offering May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Advises Citius Pharmaceuticals, LLC on a Reverse Merger and $2.04 Million Pipe Financing May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Advises Labor Smart, Inc. on a $1.1 million Private Placement of Common Stock. May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Advises Intellect Neurosciences, Inc. on $1.2 Million PIPE offering May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Advises Tonix Pharmaceuticals on $7.8 Million Public Offering May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Advises J.P. Turner & Company on $2.1 Million Private Placement for Nanox Imaging PLC May 6, 2020 Read More › Sicheniza Ross Friedman Ference Advises Cell Source Ltd. on Reverse Merger May 6, 2020 Read More › CollabRx, Inc. May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Advises NTS Inc. on $140.0 Million Acquisition Transaction May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Advises FreeSeas Inc. on $25.0 Million Public Offering of Preferred Stock and Warrants May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Advises Zenovia Digital Exchange Corp. on $5 Million Private Placement Transaction May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Advises Vuzix Corporation on a $3 Million PIPE Offering May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Advises Sorrento Therapeutics, Inc. on $25.0 million Public Offering of Common Stock May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $10 million Secondary Public Offering of Cyclacel Pharmaceuticals, Inc. May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $6.72 million Secondary Public Offering of Novabay Pharmaceuticals, Inc. May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $10 million Private Placement of Relmada Therapeutics, Inc. May 6, 2020 Read More › Sichenzia Ross Friedman Ference LLP Advises AV Therapeutics, Inc. on $1.26 million PIPE Offering May 6, 2020 Read More › « Previous 1 … 51 52 53 54 55 … 88 Next »
